Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA
LPCAT1
1 other identifier
observational
80
1 country
1
Brief Summary
Neonatal respiratory distress syndrome affects babies who are born preterm and requires them to be placed on a ventilator in the Intensive Care Unit. Over 15 million babies were born premature and these numbers have been increasing. It is caused by lungs which are still too immature to produce adequate amounts of surfactant. This surfactant reduces the alveolar surface tension and maintains the alveoli from collapsing. Collapsed alveoli prevent gas exchange and greatly increase work of breathing. Surfactant is a biochemical complex made up mostly of phospholipids such as phosphatidylcholine and phosphatidylglycerol and these, in turn, appear to be synthesized by lysophosphatidylcholine acyltransferase 1 (LPCAT 1). The investigators have previously established that hLPCAT1 mRNA in maternal serum correlates with lamellar body count, a well established clinical marker of fetal lung maturity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2018
CompletedStudy Start
First participant enrolled
June 18, 2018
CompletedFirst Posted
Study publicly available on registry
June 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedOctober 5, 2021
October 1, 2021
3.9 years
May 9, 2018
October 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in LPCAT1 mRNA levels in maternal plasma after antenatal steroid administration
The investigators will measure the level of LPCAT1 mRNA in maternal plasma before and after the administration of antenatal steroids.
The time points will be a baseline before steroids, 24h after the first dose, 24h after the second dose, a week after steroids and two weeks after steroids.
Secondary Outcomes (2)
Number of participants admitted to the NICU with high LPCAT1 mRNA levels
Through study completion, within 2 months
Correlate the LPCAT1 mRNA copy number to need for intubation in the nicu
Through study completion, within 2 months
Study Arms (2)
Women Receiving Antenatal Steroids
Group 2: Determine how (and if) serum hLPCAT1 mRNA changes with administration of a course of steroids by measuring its plasma levels before, 24hrs after the first dose and 24hrs after the second dose of bethamethasone as well as one and two week after the first dose. This is accomplished through a simple blood draw. We seek to understand the effects of the 2nd dose of steroids and determine if, once the hLPCAT1 expression begins, does it continue or does it turn off again after some time from steroid administration.
Normal Pregnancy Controls
1\) Group 1: Determine the plasma levels of hLPCAT1 mRNA in pregnant women from 32- 36+6/7 weeks gestation. This is accomplished through a simple blood draw. More specifically, we seek to find out, at what moment in gestation, expression spontaneously begins.
Interventions
Blood draw (2.5mL) to assess mRNA LPCAT1 levels
Eligibility Criteria
Patients who seek obstetrical care at Wayne State/DMC
You may qualify if:
- Singleton pregnancy, no evidence of diabetes, hypertension, smoking, BMI \> 35, Hgb \< 10 g/dl or other confounding variables
You may not qualify if:
- Smoking, abnormal gestation, multiple gestatio
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Detroit Medical Ceter
Detroit, Michigan, 48201, United States
Related Publications (4)
Welch RA, Recanati MA, Welch KC, Shaw MK. Maternal plasma LPCAT 1 mRNA correlates with lamellar body count. J Perinat Med. 2018 May 24;46(4):429-431. doi: 10.1515/jpm-2017-0057.
PMID: 28926341RESULTHarayama T, Shindou H, Shimizu T. Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J Lipid Res. 2009 Sep;50(9):1824-31. doi: 10.1194/jlr.M800500-JLR200. Epub 2009 Apr 21.
PMID: 19383981RESULTWelch RA, Shaw MK, Welch KC. Amniotic fluid LPCAT1 mRNA correlates with the lamellar body count. J Perinat Med. 2016 Jul 1;44(5):531-2. doi: 10.1515/jpm-2015-0008.
PMID: 25968427RESULTEllis B, Kaercher L, Snavely C, Zhao Y, Zou C. Lipopolysaccharide triggers nuclear import of Lpcat1 to regulate inducible gene expression in lung epithelia. World J Biol Chem. 2012 Jul 26;3(7):159-66. doi: 10.4331/wjbc.v3.i7.159.
PMID: 22905292RESULT
Biospecimen
LPCAT1 mRNA extracted from maternal plasma
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maurice Recanati, MD
Assistant Professor OBGYN
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 15 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Clinical Educator
Study Record Dates
First Submitted
May 9, 2018
First Posted
June 19, 2018
Study Start
June 18, 2018
Primary Completion
May 1, 2022
Study Completion
May 1, 2022
Last Updated
October 5, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share
No plan to share data